{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:11:11Z","timestamp":1778573471459,"version":"3.51.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Koita Centre for Digital Health, IIT Bombay","award":["DO\/2021-CFDH002-005"],"award-info":[{"award-number":["DO\/2021-CFDH002-005"]}]},{"name":"Prime Minister's Research Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Type 2 diabetes mellitus (T2DM) is a significant public health burden in India, where the disease presents with unique clinical characteristics, yet data from this high-risk population remain scarce. This study aimed to conduct a lipidomic analysis to identify candidate lipid species associated with different glycemic stages using a refined untargeted lipidomics approach. A cross-sectional study of 95 individuals from Mumbai was stratified into healthy, prediabetic, newly diagnosed diabetic, and advanced diabetic groups based on glycated hemoglobin levels. An untargeted ultra-high-performance liquid chromatography\u2013tandem mass spectrometry approach was applied to pooled serum samples to construct a comprehensive lipid library and enable comparative profiling. A stringent filtering pipeline was implemented to ensure robust lipid identification. Our analysis identified a core lipidome of 69 species shared across all cohorts, alongside an increase in lipidomic diversity in diabetic states, with the advanced diabetic group exhibiting the highest number of unique species. Ceramides (Cer) were detected across the glycemic spectrum and exhibited a distinct remodeling pattern. Partial least squares discriminant analysis identified 20 candidate lipid species with variable importance in projection scores &amp;gt;\u20091.0, prominently including Cer, phosphatidylinositol, and hexosylceramides. Additional lipid classes of interest included sphingomyelins, triacylglycerols, acylcarnitines, and fatty acids. These hypothesis-generating findings provide a prioritized framework for future large-scale quantitative validation studies aimed at early prediction and risk stratification of T2DM in the Indian population.<\/jats:p>","DOI":"10.1093\/molecular-omics\/aaiag016","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:27:07Z","timestamp":1776342427000},"source":"Crossref","is-referenced-by-count":0,"title":["Decoding the diabetic transition: a lipidomic approach for biomarker discovery in an Indian cohort"],"prefix":"10.1093","volume":"22","author":[{"given":"Sneha","family":"Singh","sequence":"first","affiliation":[{"name":"Koita Centre for Digital Health, Indian Institute of Technology Bombay , Mumbai, Maharashtra 400076 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Nagpal","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay , Mumbai, Maharashtra 400076 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-8162","authenticated-orcid":false,"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay , Mumbai, Maharashtra 400076 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026051203272256200_ref1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026051203272256200_ref2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","article-title":"Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition","volume":"6","author":"Hameed","year":"2015","journal-title":"World J Diabetes"},{"key":"2026051203272256200_ref3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026051203272256200_ref4","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India","volume":"69","author":"Pradeepa","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2026051203272256200_ref5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR\u2013INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026051203272256200_ref6","doi-asserted-by":"publisher","first-page":"e13576","DOI":"10.1111\/1753-0407.13576","article-title":"The rising prevalence of type 2 diabetes among the youth in southern India\u2014an ancillary analysis of the Secular TRends in DiabEtes in India (STRiDE-I) study","volume":"16","author":"Nanditha","year":"2024","journal-title":"J Diabetes"},{"key":"2026051203272256200_ref7","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2026051203272256200_ref8","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"2026051203272256200_ref9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MED.0000000000000533","article-title":"The emerging role of dyslipidemia in diabetic microvascular complications","volume":"27","author":"Savelieff","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2026051203272256200_ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111841","article-title":"Lipidomics\u2014reshaping the analysis and perception of type 2 diabetes","volume":"17","author":"Markgraf","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026051203272256200_ref11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126925","article-title":"Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence","volume":"5","author":"Chew","year":"2019","journal-title":"JCI Insight"},{"key":"2026051203272256200_ref12","doi-asserted-by":"publisher","first-page":"e74341","DOI":"10.1371\/journal.pone.0074341","article-title":"Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes","volume":"8","author":"Meikle","year":"2013","journal-title":"PLoS One"},{"key":"2026051203272256200_ref13","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2337\/dc18-0840","article-title":"Plasma lipidomic profiling and risk of type 2 diabetes in the PREDIMED trial","volume":"41","author":"Razquin","year":"2018","journal-title":"Diabetes Care"},{"key":"2026051203272256200_ref14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S2213-8587(14)70146-9","article-title":"Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study","volume":"2","author":"Forouhi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026051203272256200_ref15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jcjd.2018.03.009","article-title":"Assessing the levels of L-carnitine and total antioxidant capacity in adults with newly diagnosed and long-standing type 2 diabetes","volume":"43","author":"Ramazani","year":"2019","journal-title":"Can J Diabetes"},{"key":"2026051203272256200_ref16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pcd.2019.11.002","article-title":"Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: a cohort study using primary care data from the United Kingdom","volume":"14","author":"Gonz\u00e1lez-P\u00e9rez","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"2026051203272256200_ref17","doi-asserted-by":"publisher","first-page":"115214","DOI":"10.1016\/j.taap.2020.115214","article-title":"Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation","volume":"406","author":"Horska","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026051203272256200_ref18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jacl.2017.03.007","article-title":"Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes","volume":"11","author":"Kady","year":"2017","journal-title":"J Clin Lipidol"},{"key":"2026051203272256200_ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10111497","article-title":"Sphingomyelinases and liver diseases","volume":"10","author":"Insausti-Urkia","year":"2020","journal-title":"Biomolecules"},{"key":"2026051203272256200_ref20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026051203272256200_ref21","volume-title":"Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation","year":"2011"},{"key":"2026051203272256200_ref22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides\u2014lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"2026051203272256200_ref23","doi-asserted-by":"publisher","first-page":"e1003451","DOI":"10.1371\/journal.pmed.1003451","article-title":"Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China","volume":"17","author":"Yun","year":"2020","journal-title":"PLoS Med"},{"key":"2026051203272256200_ref24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1194\/jlr.S092874","article-title":"Advances in determining signaling mechanisms of ceramide and role in disease","volume":"60","author":"Stith","year":"2019","journal-title":"J Lipid Res"},{"key":"2026051203272256200_ref25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12872-023-03454-x","article-title":"Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus","volume":"23","author":"D\u00fcsing","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2026051203272256200_ref26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.advms.2022.06.001","article-title":"Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: a pilot study","volume":"67","author":"Soko\u0142owska","year":"2022","journal-title":"Adv Med Sci"},{"key":"2026051203272256200_ref27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13098-025-01731-7","article-title":"Unraveling the causal pathway between phosphatidylinositol, metabolites, and metabolic syndrome: a Mendelian randomization study","volume":"17","author":"Yang","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"2026051203272256200_ref28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway-de novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"2026051203272256200_ref29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2019.00577","article-title":"The role of ceramides in insulin resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026051203272256200_ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026051203272256200_ref31","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.4049\/jimmunol.174.5.2981","article-title":"Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP","volume":"174","author":"Lin","year":"2005","journal-title":"J Immunol"},{"key":"2026051203272256200_ref32","doi-asserted-by":"publisher","first-page":"L91","DOI":"10.1152\/ajplung.00508.2005","article-title":"Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4","volume":"291","author":"Qiao","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026051203272256200_ref33","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.cell.2011.09.045","article-title":"A conserved SREBP-1\/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans","volume":"147","author":"Walker","year":"2011","journal-title":"Cell."},{"key":"2026051203272256200_ref34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4093\/DMJ.2020.0293","article-title":"The role of adipose tissue lipolysis in diet-induced obesity: focus on vimentin","volume":"45","author":"Roh","year":"2021","journal-title":"Diabetes Metab J"},{"key":"2026051203272256200_ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214855","article-title":"Biochemical markers for the diagnosis of mitochondrial fatty acid oxidation diseases","volume":"10","author":"Ruiz-Sala","year":"2021","journal-title":"J Clin Med"},{"key":"2026051203272256200_ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci","article-title":"Lipidomic profiling of human adiposomes identifies specific lipid shifts linked to obesity and cardiometabolic risk","volume":"10","author":"Mahmoud","year":"2025","journal-title":"Clinical Research and Public Health"}],"container-title":["Molecular Omics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/advance-article-pdf\/doi\/10.1093\/molecular-omics\/aaiag016\/68090644\/aaiag016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/3\/aaiag016\/68090644\/aaiag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/3\/aaiag016\/68090644\/aaiag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:27:28Z","timestamp":1778570848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/doi\/10.1093\/molecular-omics\/aaiag016\/8655126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/molecular-omics\/aaiag016","relation":{},"ISSN":["2515-4184"],"issn-type":[{"value":"2515-4184","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,16]]},"article-number":"aaiag016"}}